Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT04492384
  4. Details
NCT04492384 Clinical Trial

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

Hypertension Clinical Trial

— ACTIV  

Official title:
Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04492384
Other study ID # ACTIV11062020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 29, 2020
Est. completion date November 29, 2021

Study information
Verified date September 2023
Source Eurasian Association of Therapists
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.

Description:

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in cohort of Russian adult patients. Retrospective analysis of medical histories and outcomes in adults with pre-existing conditions after SARS-CoV-2 infection and prospective monitoring of health status during 3, 6 and 12 months after discharge. Comorbidities worsening risk factors measuring through evaluation of range of indicators such as dynamics of diabetes, CKD, COPD, bronchial astma, incidence of hypertonic crises, vascular events and others.

Recruitment information / eligibility
Status Completed
Enrollment 6396
Est. completion date November 29, 2021
Est. primary completion date November 29, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Suspected or confirmed COVID-19. Exclusion Criteria: - Refuse to be involved in study; - Age under 18 years.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• non-interventional
Interview on health conditions

Locations
Country Name City State
Russian Federation Eurasian Association of Therapists Moscow

Sponsors (1)
Lead Sponsor Collaborator
Eurasian Association of Therapists

Country where clinical trial is conducted

Russian Federation, 

Outcome
Type Measure Description Time frame Safety issue
Primary rate of non-infectious diseases percentage of patients with non-infectious diseases relating to overall number of patients registered in study 12 month since a moment of request of medical help
Primary severity of COVID-19 depending on pre-existing diseases correlation between number of patients with COVID-19 of various severity and number of pre-existing conditions and their severity among these groups 12 month since a moment of request of medical help
Primary disability registration / change of disability status Registration of disability or change of disability status 12 month since a moment of request of medical help
Primary rate of letal outcomes rate of deaths among registered participants 12 month since a moment of request of medical help
Primary rate of letal outcomes depending on pre-existing disease correlation between number of deaths and pre-existing diseases 12 month since a moment of request of medical help
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A

External Links